rosuvastatin 10 mg tablet

DRUG2 trials

Sponsors

GlaxoSmithKline, PMV Pharmaceuticals, Inc

Conditions

Advanced Solid TumorsAnaemiaTP53 Y220C Mutation

Phase 1

Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Volunteers

CompletedNCT02371603

GlaxoSmithKlineAnaemia

Start: 2015-02-11End: 2015-08-12Updated: 2017-11-17

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

RecruitingNCT07372625

PMV Pharmaceuticals, IncAdvanced Solid Tumors, TP53 Y220C Mutation

Start: 2026-02-04End: 2028-01-01Target: 14Updated: 2026-08-12